Showing 1,031 - 1,040 of 1,415
A shortcoming of many economic evaluations is that they do not include all medical costs in life-years gained (also termed indirect medical costs). One of the reasons for this is the practical difficulties in the estimation of these costs. While some methods have been proposed to estimate...
Persistent link: https://www.econbiz.de/10010614394
Persistent link: https://www.econbiz.de/10010614396
Persistent link: https://www.econbiz.de/10010614397
Traditionally, half of the direct costs associated with chronic inflammatory bowel diseases (IBD) [Crohn's disease (CD) and ulcerative colitis (UC)] have related to hospital inpatient treatment for a sub-group of more severely affected, often therapy-resistant individuals. The advent of...
Persistent link: https://www.econbiz.de/10010614403
Persistent link: https://www.econbiz.de/10010614410
Over the past decade, public distrust in unavoidable value-laden decisions on the allocation of resources to new health technologies has grown. In response, healthcare organizations have made considerable efforts to improve their acceptability by increasing transparency in decision-making...
Persistent link: https://www.econbiz.de/10010614416
The potential benefits of influenza vaccination programmes targeted at children have gained increasing attention in recent years. We conducted a literature search of economic evaluations of influenza vaccination in those aged ≤18 years. The search revealed 20 relevant articles, which were...
Persistent link: https://www.econbiz.de/10010556696
Persistent link: https://www.econbiz.de/10010557836
Persistent link: https://www.econbiz.de/10010557843
Persistent link: https://www.econbiz.de/10010557848